公司資料
Adverum Biotechnologies 股價、新聞與催化劑
- 股票代碼:
- ADVM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for ADVM.
公司概覽
業務概覽
Adverum Biotechnologies is a gene-therapy company focused on ophthalmology and retinal disease. Its story centers on whether durable ocular gene therapy can create value in a difficult but high-unmet-need space.
所在地與產業分類
Adverum is headquartered in the United States and listed on NASDAQ. It sits in gene therapy and ophthalmology biotechnology.
商業模式特徵
The company depends on clinical and safety data, vector and manufacturing execution, and the ability to keep a narrow ocular pipeline funded. Investors watch readouts and strategic progress closely.
生技產業定位
Adverum occupies a specialized ophthalmic gene-therapy niche within biotech. The stock is catalyst-sensitive because the platform still needs to prove a strong and durable safety-efficacy balance.
未來催化劑
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。